This protocol is judged by an institutional assessment board, an unbiased team that testimonials any clinical trials involving humans. If a research consists of a Program I drug, once the board approves the protocol as moral, the scientists need to make an application for an investigational new drug (IND) range from the FDA.And they may consist of